Table of Content

1 Seasonal Influenza Vaccine Market Introduction and Overview
1.1 Seasonal Influenza Vaccine Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Seasonal Influenza Vaccine Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Seasonal Influenza Vaccine Revenue and Market Share by Type
3 Global Seasonal Influenza Vaccine Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Seasonal Influenza Vaccine Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Seasonal Influenza Vaccine Market Size (2019-2024)
4.2 Seasonal Influenza Vaccine Growth Trends Analysis by Regions
4.2.1 Seasonal Influenza Vaccine Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Seasonal Influenza Vaccine Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Seasonal Influenza Vaccine Market Size (2019-2024)
4.2.4 Europe Seasonal Influenza Vaccine Market Size (2019-2024)
4.2.5 Asia-Pacific Seasonal Influenza Vaccine Market Size (2019-2024)
4.2.6 Latin America Seasonal Influenza Vaccine Market Size (2019-2024)
4.2.7 Middle East & Africa Seasonal Influenza Vaccine Market Size (2019-2024)
5 North America
5.1 North America Seasonal Influenza Vaccine Revenue by Countries
5.1.1 North America Seasonal Influenza Vaccine Revenue by Countries (2019-2024)
5.2 North America Seasonal Influenza Vaccine Revenue by Types
5.3 North America Seasonal Influenza Vaccine Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Seasonal Influenza Vaccine Revenue by Countries
6.1.1 Asia Pacific Seasonal Influenza Vaccine Revenue by Countries (2019-2024)
6.2 Asia Pacific Seasonal Influenza Vaccine Revenue by Types
6.3 Asia Pacific Seasonal Influenza Vaccine Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Seasonal Influenza Vaccine Revenue by Countries
7.1.1 Europe Seasonal Influenza Vaccine Revenue by Countries (2019-2024)
7.2 Europe Seasonal Influenza Vaccine Revenue by Types
7.3 Europe Seasonal Influenza Vaccine Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Seasonal Influenza Vaccine Revenue by Countries
8.1.1 Latin America Seasonal Influenza Vaccine Revenue by Countries (2019-2024)
8.2 Latin America Seasonal Influenza Vaccine Revenue by Types
8.3 Latin America Seasonal Influenza Vaccine Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Seasonal Influenza Vaccine Revenue by Countries
9.1.1 Middle East & Africa Seasonal Influenza Vaccine Revenue by Countries (2019-2024)
9.2 Middle East & Africa Seasonal Influenza Vaccine Revenue by Types
9.3 Middle East & Africa Seasonal Influenza Vaccine Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Seasonal Influenza Vaccine Market Competition, by Players
10.1 Global Seasonal Influenza Vaccine Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Seasonal Influenza Vaccine Players Market Share in 2023
10.2.2 Top 6 Seasonal Influenza Vaccine Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Seasonal Influenza Vaccine Players Head Office, Business Provided
10.4 Seasonal Influenza Vaccine Mergers & Acquisitions
10.5 Seasonal Influenza Vaccine New Entrants and Expansion Plans
11 Players Profiles11.1 Novartis
11.1.1 Novartis Company Profile
11.1.2 Seasonal Influenza Vaccine Product Overview
11.1.3 Novartis Seasonal Influenza Vaccine Market Performance (2019-2024)
11.1.4 Novartis Business Overview
11.1.5 Recent Developments and Plans
11.2 Hualun Biologicals
11.2.1 Hualun Biologicals Company Profile
11.2.2 Seasonal Influenza Vaccine Product Overview
11.2.3 Hualun Biologicals Seasonal Influenza Vaccine Market Performance (2019-2024)
11.2.4 Hualun Biologicals Business Overview
11.2.5 Recent Developments and Plans
11.3 GSK
11.3.1 GSK Company Profile
11.3.2 Seasonal Influenza Vaccine Product Overview
11.3.3 GSK Seasonal Influenza Vaccine Market Performance (2019-2024)
11.3.4 GSK Business Overview
11.3.5 Recent Developments and Plans
11.4 CSL
11.4.1 CSL Company Profile
11.4.2 Seasonal Influenza Vaccine Product Overview
11.4.3 CSL Seasonal Influenza Vaccine Market Performance (2019-2024)
11.4.4 CSL Business Overview
11.4.5 Recent Developments and Plans
11.5 Sinovac Biotech
11.5.1 Sinovac Biotech Company Profile
11.5.2 Seasonal Influenza Vaccine Product Overview
11.5.3 Sinovac Biotech Seasonal Influenza Vaccine Market Performance (2019-2024)
11.5.4 Sinovac Biotech Business Overview
11.5.5 Recent Developments and Plans
11.6 Pfizer
11.6.1 Pfizer Company Profile
11.6.2 Seasonal Influenza Vaccine Product Overview
11.6.3 Pfizer Seasonal Influenza Vaccine Market Performance (2019-2024)
11.6.4 Pfizer Business Overview
11.6.5 Recent Developments and Plans
11.7 Seqirus
11.7.1 Seqirus Company Profile
11.7.2 Seasonal Influenza Vaccine Product Overview
11.7.3 Seqirus Seasonal Influenza Vaccine Market Performance (2019-2024)
11.7.4 Seqirus Business Overview
11.7.5 Recent Developments and Plans
11.8 Sanofi-Pasteur
11.8.1 Sanofi-Pasteur Company Profile
11.8.2 Seasonal Influenza Vaccine Product Overview
11.8.3 Sanofi-Pasteur Seasonal Influenza Vaccine Market Performance (2019-2024)
11.8.4 Sanofi-Pasteur Business Overview
11.8.5 Recent Developments and Plans
11.9 Solvay
11.9.1 Solvay Company Profile
11.9.2 Seasonal Influenza Vaccine Product Overview
11.9.3 Solvay Seasonal Influenza Vaccine Market Performance (2019-2024)
11.9.4 Solvay Business Overview
11.9.5 Recent Developments and Plans
11.10 MedImmune
11.10.1 MedImmune Company Profile
11.10.2 Seasonal Influenza Vaccine Product Overview
11.10.3 MedImmune Seasonal Influenza Vaccine Market Performance (2019-2024)
11.10.4 MedImmune Business Overview
11.10.5 Recent Developments and Plans
11.11 MSD
11.11.1 MSD Company Profile
11.11.2 Seasonal Influenza Vaccine Product Overview
11.11.3 MSD Seasonal Influenza Vaccine Market Performance (2019-2024)
11.11.4 MSD Business Overview
11.11.5 Recent Developments and Plans
12 Global Seasonal Influenza Vaccine Forecast Market Analysis by Type
12.1 Global Seasonal Influenza Vaccine Revenue Market Forecast by Type (2024-2030)
13 Global Seasonal Influenza Vaccine Forecast Market Analysis by Application
13.1 Seasonal Influenza Vaccine Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Seasonal Influenza Vaccine Forecast Market Size (2024-2030)
14.2 Seasonal Influenza Vaccine Growth Trends Forecast Analysis by Regions
14.2.1 Seasonal Influenza Vaccine Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Seasonal Influenza Vaccine Forecast Market Size (2024-2030)
14.2.3 Europe Seasonal Influenza Vaccine Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Seasonal Influenza Vaccine Forecast Market Size (2024-2030)
14.2.5 Latin America Seasonal Influenza Vaccine Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Seasonal Influenza Vaccine Forecast Market Size (2024-2030)
15 Seasonal Influenza Vaccine Industry Dynamic Analysis
15.1 Seasonal Influenza Vaccine Market Trends Analysis
15.2 Seasonal Influenza Vaccine Market Drivers Analysis
15.3 Seasonal Influenza Vaccine Market Challenges Analysis
15.4 Seasonal Influenza Vaccine Market Restraints Analysis